Global Gabapentin Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
Summary
Market Overview
The global Gabapentin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 1.7% in the forecast period of 2020 to 2025 and will expected to reach USD 1637.8 million by 2025, from USD 1529.6 million in 2019.
The Gabapentin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Gabapentin market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Gabapentin market has been segmented into Capsule, Tablet, etc.
By Application, Gabapentin has been segmented into Epilepsy, Neuropathic Pain, Restless Legs Syndrome, Others, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Gabapentin market presented in the report. This section sheds light on the sales growth of different regional and country-level Gabapentin markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Gabapentin market.
The report offers in-depth assessment of the growth and other aspects of the Gabapentin market in important countries (regions), including United States, Canada, Mexico, Germany, France, United Kingdom, Russia, Italy, China, Japan, Korea, India, Southeast Asia, Australia, Brazil and Saudi Arabia, etc. It also throws light on the progress of key regional Gabapentin markets such as North America, Europe, Asia-Pacific, South America and Middle East & Africa.
Competitive Landscape and Gabapentin Market Share Analysis
Gabapentin competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Gabapentin sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Gabapentin sales, revenue and market share for each player covered in this report.
The major players covered in Gabapentin are: Pfizer, Sun Pharmaceutical, Mylan, Assertio Therapeutics, Apotex, TEVA, Intas, Novartis, Arbor Pharma, Aurobindo Pharma, Jiangsu Enhua, Amneal, Jiangsu Hengrui, Alkem, Marksans Pharma, Sailike, Glenmark, etc. Among other players domestic and global, Gabapentin market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Gabapentin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Gabapentin, with price, sales, revenue and global market share of Gabapentin in 2018 and 2019.
Chapter 3, the Gabapentin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gabapentin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Gabapentin market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Gabapentin sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Gabapentin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Gabapentin Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Capsule
1.2.3 Tablet
1.3 Market Analysis by Application
1.3.1 Overview: Global Gabapentin Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Epilepsy
1.3.3 Neuropathic Pain
1.3.4 Restless Legs Syndrome
1.3.5 Others
1.4 Overview of Global Gabapentin Market
1.4.1 Global Gabapentin Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sun Pharmaceutical
2.2.1 Sun Pharmaceutical Details
2.2.2 Sun Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Sun Pharmaceutical SWOT Analysis
2.2.4 Sun Pharmaceutical Product and Services
2.2.5 Sun Pharmaceutical Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Mylan
2.3.1 Mylan Details
2.3.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Mylan SWOT Analysis
2.3.4 Mylan Product and Services
2.3.5 Mylan Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Assertio Therapeutics
2.4.1 Assertio Therapeutics Details
2.4.2 Assertio Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Assertio Therapeutics SWOT Analysis
2.4.4 Assertio Therapeutics Product and Services
2.4.5 Assertio Therapeutics Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Apotex
2.5.1 Apotex Details
2.5.2 Apotex Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Apotex SWOT Analysis
2.5.4 Apotex Product and Services
2.5.5 Apotex Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 TEVA
2.6.1 TEVA Details
2.6.2 TEVA Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 TEVA SWOT Analysis
2.6.4 TEVA Product and Services
2.6.5 TEVA Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Intas
2.7.1 Intas Details
2.7.2 Intas Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Intas SWOT Analysis
2.7.4 Intas Product and Services
2.7.5 Intas Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Novartis
2.8.1 Novartis Details
2.8.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Novartis SWOT Analysis
2.8.4 Novartis Product and Services
2.8.5 Novartis Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Arbor Pharma
2.9.1 Arbor Pharma Details
2.9.2 Arbor Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Arbor Pharma SWOT Analysis
2.9.4 Arbor Pharma Product and Services
2.9.5 Arbor Pharma Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Aurobindo Pharma
2.10.1 Aurobindo Pharma Details
2.10.2 Aurobindo Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Aurobindo Pharma SWOT Analysis
2.10.4 Aurobindo Pharma Product and Services
2.10.5 Aurobindo Pharma Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Jiangsu Enhua
2.11.1 Jiangsu Enhua Details
2.11.2 Jiangsu Enhua Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Jiangsu Enhua SWOT Analysis
2.11.4 Jiangsu Enhua Product and Services
2.11.5 Jiangsu Enhua Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Amneal
2.12.1 Amneal Details
2.12.2 Amneal Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Amneal SWOT Analysis
2.12.4 Amneal Product and Services
2.12.5 Amneal Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Jiangsu Hengrui
2.13.1 Jiangsu Hengrui Details
2.13.2 Jiangsu Hengrui Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Jiangsu Hengrui SWOT Analysis
2.13.4 Jiangsu Hengrui Product and Services
2.13.5 Jiangsu Hengrui Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Alkem
2.14.1 Alkem Details
2.14.2 Alkem Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Alkem SWOT Analysis
2.14.4 Alkem Product and Services
2.14.5 Alkem Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Marksans Pharma
2.15.1 Marksans Pharma Details
2.15.2 Marksans Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Marksans Pharma SWOT Analysis
2.15.4 Marksans Pharma Product and Services
2.15.5 Marksans Pharma Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Sailike
2.16.1 Sailike Details
2.16.2 Sailike Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Sailike SWOT Analysis
2.16.4 Sailike Product and Services
2.16.5 Sailike Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Glenmark
2.17.1 Glenmark Details
2.17.2 Glenmark Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Glenmark SWOT Analysis
2.17.4 Glenmark Product and Services
2.17.5 Glenmark Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Gabapentin Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Gabapentin Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Gabapentin Manufacturer Market Share in 2019
3.3.2 Top 6 Gabapentin Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Gabapentin Sales, Revenue and Market Share by Regions
4.1.1 Global Gabapentin Sales and Market Share by Regions (2015-2020)
4.1.2 Global Gabapentin Revenue and Market Share by Regions (2015-2020)
4.2 North America Gabapentin Sales and Growth Rate (2015-2020)
4.3 Europe Gabapentin Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Gabapentin Sales and Growth Rate (2015-2020)
4.5 South America Gabapentin Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Gabapentin Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Gabapentin Sales, Revenue and Market Share by Country
5.1.1 North America Gabapentin Sales and Market Share by Country (2015-2020)
5.1.2 North America Gabapentin Revenue and Market Share by Country (2015-2020)
5.2 United States Gabapentin Sales and Growth Rate (2015-2020)
5.3 Canada Gabapentin Sales and Growth Rate (2015-2020)
5.4 Mexico Gabapentin Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Gabapentin Sales, Revenue and Market Share by Country
6.1.1 Europe Gabapentin Sales and Market Share by Country (2015-2020)
6.1.2 Europe Gabapentin Revenue and Market Share by Country (2015-2020)
6.2 Germany Gabapentin Sales and Growth Rate (2015-2020)
6.3 UK Gabapentin Sales and Growth Rate (2015-2020)
6.4 France Gabapentin Sales and Growth Rate (2015-2020)
6.5 Russia Gabapentin Sales and Growth Rate (2015-2020)
6.6 Italy Gabapentin Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Gabapentin Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Gabapentin Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Gabapentin Revenue and Market Share by Regions (2015-2020)
7.2 China Gabapentin Sales and Growth Rate (2015-2020)
7.3 Japan Gabapentin Sales and Growth Rate (2015-2020)
7.4 Korea Gabapentin Sales and Growth Rate (2015-2020)
7.5 India Gabapentin Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Gabapentin Sales and Growth Rate (2015-2020)
7.7 Australia Gabapentin Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Gabapentin Sales, Revenue and Market Share by Country
8.1.1 South America Gabapentin Sales and Market Share by Country (2015-2020)
8.1.2 South America Gabapentin Revenue and Market Share by Country (2015-2020)
8.2 Brazil Gabapentin Sales and Growth Rate (2015-2020)
8.3 Argentina Gabapentin Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Gabapentin Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Gabapentin Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Gabapentin Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Gabapentin Sales and Growth Rate (2015-2020)
9.3 Turkey Gabapentin Sales and Growth Rate (2015-2020)
9.4 Egypt Gabapentin Sales and Growth Rate (2015-2020)
9.5 South Africa Gabapentin Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Gabapentin Sales and Market Share by Type (2015-2020)
10.2 Global Gabapentin Revenue and Market Share by Type (2015-2020)
10.3 Global Gabapentin Price by Type (2015-2020)
11 Global Gabapentin Market Segment by Application
11.1 Global Gabapentin Sales Market Share by Application (2015-2020)
11.2 Global Gabapentin Revenue Market Share by Application (2015-2020)
11.3 Global Gabapentin Price by Application (2015-2020)
12 Market Forecast
12.1 Global Gabapentin Sales, Revenue and Growth Rate (2021-2025)
12.2 Gabapentin Market Forecast by Regions (2021-2025)
12.2.1 North America Gabapentin Market Forecast (2021-2025)
12.2.2 Europe Gabapentin Market Forecast (2021-2025)
12.2.3 Asia-Pacific Gabapentin Market Forecast (2021-2025)
12.2.4 South America Gabapentin Market Forecast (2021-2025)
12.2.5 Middle East & Africa Gabapentin Market Forecast (2021-2025)
12.3 Gabapentin Market Forecast by Type (2021-2025)
12.3.1 Global Gabapentin Sales Forecast by Type (2021-2025)
12.3.2 Global Gabapentin Market Share Forecast by Type (2021-2025)
12.4 Gabapentin Market Forecast by Application (2021-2025)
12.4.1 Global Gabapentin Sales Forecast by Application (2021-2025)
12.4.2 Global Gabapentin Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Tables and Figures
List of Tables
Table 1. Global Gabapentin Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Gabapentin by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Gabapentin Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Gabapentin Major Business
Table 9. Pfizer Gabapentin Total Revenue (USD Million) (2017-2018)
Table 10. Pfizer SWOT Analysis
Table 11. Pfizer Gabapentin Product and Services
Table 12. Pfizer Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 14. Sun Pharmaceutical Gabapentin Major Business
Table 15. Sun Pharmaceutical Gabapentin Total Revenue (USD Million) (2017-2018)
Table 16. Sun Pharmaceutical SWOT Analysis
Table 17. Sun Pharmaceutical Gabapentin Product and Services
Table 18. Sun Pharmaceutical Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Mylan Basic Information, Manufacturing Base and Competitors
Table 20. Mylan Gabapentin Major Business
Table 21. Mylan Gabapentin Total Revenue (USD Million) (2017-2018)
Table 22. Mylan SWOT Analysis
Table 23. Mylan Gabapentin Product and Services
Table 24. Mylan Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Assertio Therapeutics Basic Information, Manufacturing Base and Competitors
Table 26. Assertio Therapeutics Gabapentin Major Business
Table 27. Assertio Therapeutics Gabapentin Total Revenue (USD Million) (2017-2018)
Table 28. Assertio Therapeutics SWOT Analysis
Table 29. Assertio Therapeutics Gabapentin Product and Services
Table 30. Assertio Therapeutics Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Apotex Basic Information, Manufacturing Base and Competitors
Table 32. Apotex Gabapentin Major Business
Table 33. Apotex Gabapentin Total Revenue (USD Million) (2017-2018)
Table 34. Apotex SWOT Analysis
Table 35. Apotex Gabapentin Product and Services
Table 36. Apotex Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. TEVA Basic Information, Manufacturing Base and Competitors
Table 38. TEVA Gabapentin Major Business
Table 39. TEVA Gabapentin Total Revenue (USD Million) (2017-2018)
Table 40. TEVA SWOT Analysis
Table 41. TEVA Gabapentin Product and Services
Table 42. TEVA Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Intas Basic Information, Manufacturing Base and Competitors
Table 44. Intas Gabapentin Major Business
Table 45. Intas Gabapentin Total Revenue (USD Million) (2017-2018)
Table 46. Intas SWOT Analysis
Table 47. Intas Gabapentin Product and Services
Table 48. Intas Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Novartis Basic Information, Manufacturing Base and Competitors
Table 50. Novartis Gabapentin Major Business
Table 51. Novartis Gabapentin Total Revenue (USD Million) (2017-2018)
Table 52. Novartis SWOT Analysis
Table 53. Novartis Gabapentin Product and Services
Table 54. Novartis Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Arbor Pharma Basic Information, Manufacturing Base and Competitors
Table 56. Arbor Pharma Gabapentin Major Business
Table 57. Arbor Pharma Gabapentin Total Revenue (USD Million) (2017-2018)
Table 58. Arbor Pharma SWOT Analysis
Table 59. Arbor Pharma Gabapentin Product and Services
Table 60. Arbor Pharma Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 62. Aurobindo Pharma Gabapentin Major Business
Table 63. Aurobindo Pharma Gabapentin Total Revenue (USD Million) (2017-2018)
Table 64. Aurobindo Pharma SWOT Analysis
Table 65. Aurobindo Pharma Gabapentin Product and Services
Table 66. Aurobindo Pharma Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Jiangsu Enhua Basic Information, Manufacturing Base and Competitors
Table 68. Jiangsu Enhua Gabapentin Major Business
Table 69. Jiangsu Enhua Gabapentin Total Revenue (USD Million) (2017-2018)
Table 70. Jiangsu Enhua SWOT Analysis
Table 71. Jiangsu Enhua Gabapentin Product and Services
Table 72. Jiangsu Enhua Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Amneal Basic Information, Manufacturing Base and Competitors
Table 74. Amneal Gabapentin Major Business
Table 75. Amneal Gabapentin Total Revenue (USD Million) (2017-2018)
Table 76. Amneal SWOT Analysis
Table 77. Amneal Gabapentin Product and Services
Table 78. Amneal Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Jiangsu Hengrui Basic Information, Manufacturing Base and Competitors
Table 80. Jiangsu Hengrui Gabapentin Major Business
Table 81. Jiangsu Hengrui Gabapentin Total Revenue (USD Million) (2017-2018)
Table 82. Jiangsu Hengrui SWOT Analysis
Table 83. Jiangsu Hengrui Gabapentin Product and Services
Table 84. Jiangsu Hengrui Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Alkem Basic Information, Manufacturing Base and Competitors
Table 86. Alkem Gabapentin Major Business
Table 87. Alkem Gabapentin Total Revenue (USD Million) (2017-2018)
Table 88. Alkem SWOT Analysis
Table 89. Alkem Gabapentin Product and Services
Table 90. Alkem Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Marksans Pharma Basic Information, Manufacturing Base and Competitors
Table 92. Marksans Pharma Gabapentin Major Business
Table 93. Marksans Pharma Gabapentin Total Revenue (USD Million) (2017-2018)
Table 94. Marksans Pharma SWOT Analysis
Table 95. Marksans Pharma Gabapentin Product and Services
Table 96. Marksans Pharma Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Sailike Basic Information, Manufacturing Base and Competitors
Table 98. Sailike Gabapentin Major Business
Table 99. Sailike Gabapentin Total Revenue (USD Million) (2017-2018)
Table 100. Sailike SWOT Analysis
Table 101. Sailike Gabapentin Product and Services
Table 102. Sailike Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. Glenmark Basic Information, Manufacturing Base and Competitors
Table 104. Glenmark Gabapentin Major Business
Table 105. Glenmark Gabapentin Total Revenue (USD Million) (2017-2018)
Table 106. Glenmark SWOT Analysis
Table 107. Glenmark Gabapentin Product and Services
Table 108. Glenmark Gabapentin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 109. Global Gabapentin Sales by Manufacturer (2018-2019) (K MT)
Table 110. Global Gabapentin Revenue by Manufacturer (2018-2019) (USD Million)
Table 111. Global Gabapentin Sales by Regions (2015-2020) (K MT)
Table 112. Global Gabapentin Sales Market Share by Regions (2015-2020)
Table 113. Global Gabapentin Revenue by Regions (2015-2020) (USD Million)
Table 114. North America Gabapentin Sales by Countries (2015-2020) (K MT)
Table 115. North America Gabapentin Sales Market Share by Countries (2015-2020)
Table 116. North America Gabapentin Revenue by Countries (2015-2020) (USD Million)
Table 117. North America Gabapentin Revenue Market Share by Countries (2015-2020)
Table 118. Europe Gabapentin Sales by Countries (2015-2020) (K MT)
Table 119. Europe Gabapentin Sales Market Share by Countries (2015-2020)
Table 120. Europe Gabapentin Revenue by Countries (2015-2020) (USD Million)
Table 121. Asia-Pacific Gabapentin Sales by Regions (2015-2020) (K MT)
Table 122. Asia-Pacific Gabapentin Sales Market Share by Regions (2015-2020)
Table 123. Asia-Pacific Gabapentin Revenue by Regions (2015-2020) (USD Million)
Table 124. South America Gabapentin Sales by Countries (2015-2020) (K MT)
Table 125. South America Gabapentin Sales Market Share by Countries (2015-2020)
Table 126. South America Gabapentin Revenue by Countries (2015-2020) (USD Million)
Table 127. South America Gabapentin Revenue Market Share by Countries (2015-2020)
Table 128. Middle East & Africa Gabapentin Sales by Countries (2015-2020) (K MT)
Table 129. Middle East & Africa Gabapentin Sales Market Share by Countries (2015-2020)
Table 130. Middle East & Africa Gabapentin Revenue by Countries (2015-2020) (USD Million)
Table 131. Middle East & Africa Gabapentin Revenue Market Share by Countries (2015-2020)
Table 132. Global Gabapentin Sales by Type (2015-2020) (K MT)
Table 133. Global Gabapentin Sales Share by Type (2015-2020)
Table 134. Global Gabapentin Revenue by Type (2015-2020) (USD Million)
Table 135. Global Gabapentin Revenue Share by Type (2015-2020)
Table 136. Global Gabapentin Sales by Application (2015-2020) (K MT)
Table 137. Global Gabapentin Sales Share by Application (2015-2020)
Table 138. Global Gabapentin Sales Forecast by Regions (2021-2025) (K MT)
Table 139. Global Gabapentin Market Share Forecast by Regions (2021-2025)
Table 140. Global Gabapentin Sales Forecast by Type (2021-2025) (K MT)
Table 141. Global Gabapentin Market Share Forecast by Type (2021-2025)
Table 142. Global Gabapentin Sales Forecast by Application (2021-2025)
Table 143. Global Gabapentin Market Share Forecast by Application (2021-2025)
Table 144. Direct Channel Pros & Cons
Table 145. Indirect Channel Pros & Cons
Table 146. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Gabapentin Picture
Figure 2. Global Sales Market Share of Gabapentin by Type in 2019
Figure 3. Capsule Picture
Figure 4. Tablet Picture
Figure 5. Gabapentin Sales Market Share by Application in 2018
Figure 6. Epilepsy Picture
Figure 7. Neuropathic Pain Picture
Figure 8. Restless Legs Syndrome Picture
Figure 9. Others Picture
Figure 10. Global Gabapentin Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Gabapentin Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Gabapentin Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Gabapentin Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Gabapentin Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Gabapentin Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Gabapentin Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Gabapentin Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Gabapentin Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Gabapentin Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Gabapentin Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Gabapentin Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Gabapentin Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Gabapentin Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Gabapentin Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Gabapentin Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Gabapentin Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Gabapentin Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Gabapentin Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Gabapentin Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Gabapentin Sales Market Share by Manufacturer in 2019
Figure 31. Global Gabapentin Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Gabapentin Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Gabapentin Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Gabapentin Sales and Growth Rate (2015-2020) (K MT)
Figure 36. Global Gabapentin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Gabapentin Revenue Market Share by Regions (2015-2020)
Figure 38. Global Gabapentin Revenue Market Share by Regions in 2018
Figure 39. North America Gabapentin Sales and Growth Rate (2015-2020)
Figure 40. Europe Gabapentin Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Gabapentin Sales and Growth Rate (2015-2020)
Figure 42. South America Gabapentin Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Gabapentin Sales and Growth Rate (2015-2020)
Figure 44. North America Gabapentin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Gabapentin Sales Market Share by Countries (2015-2020)
Figure 46. North America Gabapentin Sales Market Share by Countries in 2018
Figure 47. North America Gabapentin Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Gabapentin Revenue Market Share by Countries in 2018
Figure 49. United States Gabapentin Sales and Growth Rate (2015-2020) (K MT)
Figure 50. Canada Gabapentin Sales and Growth Rate (2015-2020) (K MT)
Figure 51. Mexico Gabapentin Sales and Growth Rate (2015-2020) (K MT)
Figure 52. Europe Gabapentin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Gabapentin Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Gabapentin Revenue Market Share by Countries in 2019
Figure 55. Germany Gabapentin Sales and Growth Rate (2015-2020) (K MT)
Figure 56. UK Gabapentin Sales and Growth Rate (2015-2020) (K MT)
Figure 57. France Gabapentin Sales and Growth Rate (2015-2020) (K MT)
Figure 58. Russia Gabapentin Sales and Growth Rate (2015-2020) (K MT)
Figure 59. Italy Gabapentin Sales and Growth Rate (2015-2020) (K MT)
Figure 60. Asia-Pacific Gabapentin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Gabapentin Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Gabapentin Revenue Market Share by Regions 2019
Figure 63. China Gabapentin Sales and Growth Rate (2015-2020) (K MT)
Figure 64. Japan Gabapentin Sales and Growth Rate (2015-2020) (K MT)
Figure 65. Korea Gabapentin Sales and Growth Rate (2015-2020) (K MT)
Figure 66. India Gabapentin Sales and Growth Rate (2015-2020) (K MT)
Figure 67. Southeast Asia Gabapentin Sales and Growth Rate (2015-2020) (K MT)
Figure 68. South America Gabapentin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Gabapentin Sales Market Share by Countries in 2019
Figure 70. South America Gabapentin Revenue Market Share by Countries in 2019
Figure 71. Brazil Gabapentin Sales and Growth Rate (2015-2020) (K MT)
Figure 72. Argentina Gabapentin Sales and Growth Rate (2015-2020) (K MT)
Figure 73. Middle East and Africa Gabapentin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Gabapentin Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Gabapentin Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Gabapentin Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Gabapentin Sales and Growth Rate (2015-2020) (K MT)
Figure 78. Egypt Gabapentin Sales and Growth Rate (2015-2020) (K MT)
Figure 79. Turkey Gabapentin Sales and Growth Rate (2015-2020) (K MT)
Figure 80. South Africa Gabapentin Sales and Growth Rate (2015-2020) (K MT)
Figure 81. Global Gabapentin Sales and Growth Rate (2021-2025) (K MT)
Figure 82. Global Gabapentin Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Gabapentin Market Forecast (2021-2025) (K MT)
Figure 84. Europe Sales Gabapentin Market Forecast (2021-2025) (K MT)
Figure 85. Asia-Pacific Sales Gabapentin Market Forecast (2021-2025) (K MT)
Figure 86. South America Sales Gabapentin Market Forecast (2021-2025) (K MT)
Figure 87. Middle East & Africa Sales Gabapentin Market Forecast (2021-2025) (K MT)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets